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ABSTRACT We have identified and cloned herculin, a
fourth mouse muscle regulatory gene. Comparison of its DNA
and deduced amino acid sequences with those of the three
known myogenic genes (MyoD, myogenin, and Myf-5) reveals
scattered short spans with similarity to one or more of these
genes and a long span with strong similarity to all three. This
long span includes a sequence motif that is also present in
proteins of the myc, achaete-scute, and immunoglobulin en-
hancer-binding families. The herculin gene is physically linked
to the Myf-5 gene on the chromosome; only 8.5 kilobases
separate their translational start sites. A putative 27-kDa
protein is encoded by three exons contained within a 1.7-
kilobase fragment of the herculin gene. When expressed under
the control of the simian virus 40 early promoter, transfected
herculin renders murine NIH 3T3 and C3H/lOTY4 fibroblasts
myogenic. In doing so, it also activates expression ofmyogenin,
MyoD, and endogenous herculin in NIH 3T3 recipients. In
adult mice, herculin is expressed in skeletal muscle but is absent
from smooth muscle, cardiac muscle, and all nonmuscle tissues
assayed. Direct comparison of the four known myogenic reg-
ulators in adult muscle showed that herculin is expressed at a
significantly higher level than is any of the others. This
quantitative dominance suggests an important role in the
establishment or maintenance of adult skeletal muscle.
sequence-specific DNA-binding proteins, and the shared
protein motif is essential for binding (7). MyoD, for example,
binds to the mouse muscle creatine kinase enhancer in vitro
(8).
While all skeletal muscle is thought to develop by the
progression outlined above, the types of differentiated cells
produced are phenotypically diverse. For example, several
subtypes of fast- and slow-contracting fibers exist in fetal and
adult skeletal muscle, and this diversity is thought to be a
product of developmental history and, in some instances,
function (reviewed in ref. 9). These skeletal muscle types
express partially overlapping but distinct sets of muscle-
specific gene products, implying the existence of a corre-
spondingly diverse and subtle system of muscle gene regu-
lation. This may be provided, at least in part, by different
myogenic regulators of the MyoD type acting alone or in
specific combinations. In this work we report the cloning and
characterization* of herculin, a fourth member of the myo-
genic regulatory family. Among the presently known myo-
genic regulatory factors, it is the quantitatively dominant
species in adult muscle, suggesting a major role in differen-
tiation and/or maturation of adult skeletal muscle. Its capac-
ity to activate expression of some other members of the
family in cell culture experiments is shown, and implications
of these results for regulatory pathways in vivo are discussed.
Cell lineage studies have led to a description of myogenesis
as a stepwise developmental progression beginning with a
multipotential mesodermal stem cell and ending in a termi-
nally differentiated, multinucleated myotube. The first step in
this process produces from a multipotential precursor cell a
determined myoblast that still possesses the ability to pro-
liferate but is now committed to the myogenic pathway. A
second distinct step involves withdrawal of the myoblast
from the cell cycle and activation of a battery of muscle-
specific genes, such as those encoding contractile proteins
and metabolic enzymes that identify the cell as a myocyte.
Subsequent maturation into functional skeletal muscle in-
cludes fusion to form multinucleated myotubes of several
distinct types.
A crucial step in understanding the regulation of this
developmental pathway was the cloning by Davis et al. (1) of
MyoD cDNA, which upon transfection converts a variety of
nonmyogenic cells into functional myoblasts (2). Yet MyoD
has turned out to be but one member of a family of myogenic
genes, which also includes myogenin (3, 4) and Myf-5 (5).
Each can initiate myogenesis in a transfection assay, and
their products share one very similar protein sequence that is
also characteristic of a larger, extended family of nuclear
proteins that includes the myc family, Drosophila achaete-
scute complex products and immunoglobulin enhancer-
binding proteins (1, 6). Some of these have been shown to be
MATERIALS AND METHODS
Identification ofMouse Myf-S-Positive Plaques. The BALB/
c spleen Charon 4A mouse library was a gift from R.
Perlmutter and L. Hood (California Institute of Technology).
Plaques were transferred to Hybond-N nylon circles (Amer-
sham) and hybridized to human Myf-5 cDNA probe (a gift
from H. Arnold, University of Hamburg Medical School) at
42°C overnight in a solution containing 40% formamide, 6X
SSPE (lx SSPE = 0.18 M NaCl/10 mM phosphate, pH 7.4/1
mM EDTA), 0.1% bovine serum albumin, 0.1% Ficoll, 0.1%
polyvinylpyrrolidone, 50 mM sodium phosphate (pH 6.5),
0.5% NaDodSO4, and 50 ,ug of salmon sperm DNA per ml.
DNA Sequencing. After restriction mapping, fragments of
phage insert DNA were subcloned into Bluescript II KS+
(Stratagene) by standard methods (10) and sequenced with a
Sequenase DNA sequencing kit (United States Biochemical)
with T3 (Stratagene) and T7 (Promega) promoter primers.
Cell Culture and Analysis. NIH 3T3 cells were grown in
90% (vol/vol) Dulbecco's modified Eagle's medium
(DMEM) containing 10% (vol/vol) calf serum (both GIBCO).
C3H/1OT'/2 cells were grown in 90% DMEM/10% (vol/vol)
fetal bovine serum (Hazleton Research Products, Lenexa,
KS). Cells on 10-cm plates were transfected by a standard
calcium phosphate coprecipitation with 5 or 10 ,ug of the
herculin expression vector pSVhrc, 0.5 ,ug of pY3, which
provides resistance to hygromycin B (11), and enough non-
*The sequence reported in this paper has been deposited in the
GenBank data base (accession no. M30499).
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specific plasmid or L-cell DNA to make 15 Ag. After 12 hr of
exposure to DNA, cells were fed fresh medium. After an-
other 24 hr, the medium was changed to DMEM containing
200 Ag of hygromycin B (Calbiochem) per ml and one of the
following: 10% calf serum, 2.5% fetal bovine serum (NIH 3T3
cells), or 15% fetal bovine serum (C3H/10T/2 cells) to select
stable transformants. Alternatively, to induce myogenesis in
a transient assay for myogenic activity, the medium was
changed to DMEM containing 2% horse serum (Flow Lab-
oratories) and 2 ,ug of insulin (GIBCO) per ml for 3 days, after
which the cells were fixed and immunocytochemically
stained for myosin heavy chain (as in ref. 1) with Amersham
reagents.
RNA Isolation and Analysis. RNAs were prepared by the
method of Chomczynski and Sacchi (12). Riboprobes were
synthesized from Bluescript I- or II-based templates. Hy-
bridizations for RNase protections were done in 30 A.l of80%deionized formamide/40mM Pipes, pH 6.4/1 mM EDTA/0.4
M NaCl under mineral oil at 50'C for 12 hr. Unhybridized
probes were digested with 300 units of RNase T1 (BRL) at
30'C for 30 min.
RESULTS AND DISCUSSION
A Phage Containing Myf-5 Also Contains the Related Her-
culin Gene. To isolate a fragment of the mouse Myf-5 gene,
we screened a BALB/c spleen genomic library at reduced
stringency with the 750 base pair (bp) Pst I-Pvu II fragment
of human Myf-5 cDNA (5). This fragment, which does not
contain the myc homology region of Myf-5, was chosen to
avoid cross-reaction with MyoD and myogenin. Six repro-
ducibly positive plaques were identified, and restriction
analyses of their inserts indicated there were two distinct
clones among them that represented both possible orienta-
tions of the same 14.5-kilobase (kb) genomic insert. More
detailed restriction mapping and Southern DNA transfer
analyses led to the map of the phage insert shown in Fig. 1.
The analysis also revealed two separate myc homologies
approximately 8 kb apart, suggesting the presence of two
different genes. The DNA sequence within and adjacent to
both myc homologies was determined, and it confirmed that
one was indeed part of the mouse Myf-5 gene and that the
other, 8.5 kb upstream, was part of a new but related gene,
which we have named "herculin." Their restriction maps are
also shown in Fig. 1. The fact that two independent clones
with identical insert maps were isolated suggested a true
linkage, not linkage by cloning artifact. To confirm linkage in
the genome, Southern blots ofKpn I-digested mouse genomic
DNA were probed with two gene-specific fragments (see the
legend to Fig. 1) either separately or together. From the
phage map, Kpn I is expected to produce a 9-kb chromosomal
segment containing both fragments, and in all three cases the
probes did identify a single 9-kb hybridizing band (data not
shown).
Sequence of the Herculin Gene Reveals Regions Similar to
MyoD, Myogenin, and Myf-S. The nucleotide sequence and
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predicted amino acid sequence of herculin are shown in Fig.
2A. The DNA sequence extends from a consensus TATA
element locatedjust upstream ofthe Sal I site to the Xba I site
located 3' of an in-frame TAA stop codon. Assignments of
internal exon boundaries were confuimed by sequence anal-
ysis of products derived by polymerase chain reaction am-
plification of herculin cDNA from skeletal muscle (which
expresses herculin-see below).
The initial basis for proposing the putative 27-kDa protein
to be a member of the MyoD family is its strong identity with
MyoD, myogenin, and Myf-5 over the 57 amino acid span
boxed in Fig. 2A and reproduced for comparisons in Fig. 2B.
Similar domains are found in proteins of the MYC, Droso-
phila achaete-scute, and immunoglobulin enhancer-binding
families and include the proposed helix-loop-helix motif (6),
which is known to be important for protein dimerization and
DNA binding (7). Within this region the herculin protein is
most identical to the myogenic regulators myogenin (82%),
MyoD (81%), and Myf-5 (79%). MyoD and Myf-5 are the
most closely related pair in the family, having 89%o identity in
this region. By contrast, the relatedness of herculin to
nonmyogenic molecules such as c-myc and E12 is only 33%
and 36%, respectively.
In addition to the similarity delineated by the box, there are
other amino acids conserved among all four myogenic regu-
lators, the majority of which are in a region just upstream of
the box, and these are shown as shaded in Fig. 2A. There are
no other extended regions of amino acid similarity shared by
all four molecules, but there are many scattered spans of
homology shared by herculin and only one or two ofthe other
myogenic molecules, the most unusual being a stretch be-
tween amino acid residues 214 and 229. In this region, the
herculin protein sequence is similar to MyoD and Myf-5 but
not to myogenin. However, the corresponding nucleic acid
sequence reveals a striking homology shared by all four. This
can be explained by a difference in reading frame caused by
the apparent deletion of a base from myogenin relative to the
other three. The surprising apparent conservation of 48
nucleotides of myogenin DNA following a frameshifting
event may suggest that this was a relatively recent occur-
rence or that there is some independent selective pressure for
conservation of this sequence in DNA or in RNA.
Expression of Herculin Is Confined to Skeletal Muscle in an
Adult Mouse. Fig. 3 shows the result of a RNase protection
experiment designed to detect herculin transcripts in the
indicated adult mouse tissues. By this sensitive assay,
expression of herculin was confined to skeletal muscle; no
transcripts were detected in smooth muscle or cardiac muscle
or in other tissues. This pattern is not surprising, since MyoD
and myogenin are also exclusively expressed in skeletal
muscle. However, Myf-5, the nearby chromosomal neighbor
of the herculin gene, is reported to be expressed in both
skeletal and smooth muscle (5). This indicates that despite
their proximity in the genome, the genes for herculin and
Myf-5 must be subject to independent regulation, at least in
the context of smooth muscle. However, coregulation in
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FIG. 1. Phage and plasmid maps showing the genomic organization of herculin and Myf-5 genes. Boxes identify exons, shading indicates
the shared myc sequence similarity, and arrows indicate direction of transcription. Only the first exon and part of the first intron of Myf-5 have
been mapped and sequenced; the dotted line represents a portion of the gene not yet analyzed. B, BamHI; H, HindIII; P. Pst I; R, EcoRI; S,
Sac I; X, Xba I. Southern blot probes were the Pst I-Sac I fragment of the herculin gene and the Sac I-HindIII fragment of Myf-5.
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FIG. 2. Nucleotide sequence of the herculin gene and the deduced amino acid sequence of herculin (A) and comparison of the myc similarity
motifs from the indicated proteins (B). The boxed amino acids in A comprise this shared motif, and shading outside the box denotes other amino
acid spans common to all four proteins. Stars in B denote amino acid positions with the most variability among the molecules in this region.
skeletal muscle by one or more shared cis-acting elements is
possible, since both genes are expressed there.
Herculin Is Myogenic in NIH 3T3 and C3H/1OT'/2 Cell
Backgrounds. To determine whether the sequence similari-
ties between herculin and the other MyoD-related molecules
reflect functional similarities, the 1.7-kb Sal I-Xba I fragment
of the herculin gene, which contains the entire putative
coding region, was inserted into the expression vector pECE
(13). pECE contains a polylinker flanked by the simian virus
40 early promoter and the tumor antigen polyadenylylation
signal sequence. The resulting plasmid, pSVhrc, was trans-
fected by calcium phosphate coprecipitation into NIH 3T3
and C3H/1OT'/2 cells together with a selectable marker.
These host cells are not myogenic prior to transfection, but
herculin expression was found to induce myogenesis in both
lines. This was demonstrated in a transient assay by the
appearance of myosin heavy chain in individual cells detected
by immunostaining (data not shown). The efficiency with
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FIG. 3. RNase protection analysis of herculin gene expression in
adult mouse tissues. Ten micrograms of total RNA from each tissue
was hybridized to an antisense herculin riboprobe extending from
nucleotide 321 (Pst 1) to 12 (Sal I).
which the herculin vector induced myogenic cells was ap-
proximately the same as that of an analogous MyoD vector
in a parallel experiment. Transfection with the pECE vector
alone did not produce any myogenic cells.
An interesting and potentially important property ofMyoD
is that it can, in some recipient cells, activate expression of
endogenous MyoD, demonstrating a positive autoregulatory
pathway (14). We asked whether cells stably transfected with
herculin similarly activated the endogenous herculin gene or
any of the other cloned myogenic regulatory genes. Stable
herculin-transfected NIH 3T3 cells were pooled and cultured
under conditions that promoted either proliferation (12.5%
serum) or differentiation (2% serum for 3 days). Total cellular
RNA was extracted and analyzed by RNase protection
assays for expression of herculin, myogenin, and MyoD (Fig.
4). Myogenin was activated by herculin but only under
differentiation conditions; this is a pattern consistent with
myogenin's behavior in other myogenic cell lines (Fig. 4B),
where it is always expressed upon differentiation. The MyoD
and herculin probes are designed to distinguish between
endogenous transcripts and those derived from the trans-
fected constructs. The data in Fig. 4C demonstrate that
exogenous herculin activates endogenous MyoD in NIH 3T3
cells, and this activation is most pronounced in cells that have
differentiated. The results in Fig. 4A show that herculin
transformation of NIH 3T3 cells can also activate expression
of the endogenous herculin gene, and preliminary experi-
ments suggest a low-level activation of Myf-S in these cells as
well (J.H.M., unpublished observations). We conclude that
herculin can act as a powerful member of the myogenic
regulatory network. Its capacity to activate, either directly or
indirectly, MyoD, myogenin, endogenous herculin, and Myf-
5 argues for a potentially complex network of interactions
involving the MyoD family members. It is clear that host-cell
characteristics also play a significant role in defining the
Developmental Biology: Miner and Wold
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FIG. 4. RNase protection analyses of herculin, myogenin, and
MyoD gene expression in cell lines under conditions of proliferation
(lanes P) or differentiation (lanes D). (A and B) Separate experiments
in which 10 ,tg of total RNA from each cell line was hybridized to the
following riboprobes: herculin, which was the same as in Fig. 3;
myogenin, which extended from nucleotide 218 (Sma I) to 35 (Sty I)
(4); MyoD, which extended from an extragenic BamHI site in the
MyoD expression vehicle pEMc11s to nucleotide 1692 (Sty I) of
MyoD cDNA (1). The low level of myogenin expression in prolif-
erating C2C12 and MM14 populations is probably due to a small
number of spontaneously differentiated cells. (C) Results of addi-
tional studies with the MyoD riboprobe alone. Lanes: 1, differenti-
ated MyoD-transformed NIH 3T3 cells; 2, differentiated aza-
myoblasts; 3, yeast RNA; 4, proliferating herculin-transformed NIH
3T3 cells; 5, differentiated herculin-transformed NIH 3T3 cells; 6,
differentiated C2C12 cells; and 7, yeast RNA. C2C12 cells were
grown in 80%o DMEM/20% fetal bovine serum and differentiated in
98% DMEM/2% horse serum/2 Ag of insulin per ml for 2 days.
MM14 cells were grown and differentiated as in ref. 15.
network. In the NIH 3T3 cells studied here, MyoD transfec-
tion activates myogenin expression but fails to activate
herculin (Fig. 4A), Myf-S (data not shown) or endogenous
MyoD (Fig. 4C). By contrast, in C3H/10T/2 cells, exogenous
MyoD does activate its endogenous counterpart (14). There-
fore, we expect that host-cell properties are influencing
herculin regulatory activity in our cell culture experiments
and, very likely, play a significant role in the developing
animal as well. Although the importance of host-cell factors
cautions against a facile generalization from cell culture
model systems to myogenesis in vivo, the potent activity of
the herculin gene in transfection studies does reveal a circuit
for extensive cross-talk between herculin and other family
members. This circuitry may prove to be important in vivo for
initiating a developmental decision or for reinforcing one,
once made.
A variety of other muscle cell lines was also examined, and
C2C12 (16) was found to be the only one that, under our
culture conditions, expressed herculin at detectable levels.
MM14 cells (17) and aza-myoblasts (derived by 5-azacytidine
treatment of C3H/1OTh/2 cells) (1) did not express herculin
(Fig. 4A and data not shown). Thus, some independently
derived lines can differentiate without detectable expression
of herculin, demonstrating that it is neither essential for
maintenance of the myoblast phenotype nor for differentia-
tion into muscle. Also, it is notable that in this range of cell
types, expression of MyoD or myogenin has not activated
expression of herculin. It is not known, however, if any of
these lines expressed herculin at some earlier point in their
developmental history. The tissue explant-derived line that
does express herculin, C2C12, also expresses all of the other
family members, and in this respect is similar to herculin-
transfected NIH 3T3 cells. Other lines examined express, in
the differentiated state, various pairwise combinations of
myogenin with only one other member.
Expression of Herculin in Vivo Is High Compared with
MyoD, Myogenin, and Myf-S. To begin to compare herculin
expression in the animal with its activity in cell culture, we
measured the relative levels of expression of muscle regula-
tory genes in adult skeletal muscle by RNase protection
assays (Fig. 5) using riboprobes for myogenin and Myf-5 (lane
1), herculin (lane 2), and MyoD (lane 3). Probes were
synthesized such that the nuclease-protected probe frag-
ments for each of the four had identical specific activities on
a molar basis. Thus, the intensity ofeach band is proportional
to its relative abundance in total RNA from adult skeletal
muscle. It is evident that herculin RNA is by far the most
prevalent.
Because herculin is the most abundant of the four known
myogenic molecules in this tissue, it seems likely that it plays
a significant role in the maintenance of the skeletal muscle
phenotype in adults. However, it remains to be determined
whether herculin is globally expressed in all mature adult
skeletal muscle or is restricted to a specific subset of muscle
cell types or physiological states. The possibility that herculin
is differentially expressed among different muscle cell pop-
ulations is part of the more general question concerning the
roles played by each MyoD family member in muscle tissue
and its developmental precursors. Lineage studies suggest
that there are different precursor myoblast populations in
developing muscle that give rise to distinct muscle fiber types
(9). It seems likely that the ultimate differentiated phenotype
ofthese species of skeletal myocytes may be dictated, at least
in part, by their patterns of expression of MyoD, myogenin,
Myf-5, herculin, and perhaps Myd (18) and ski (19) during
development and upon maturation. A comprehensive picture
of the pattern of expression for each of these regulators
during the life history of a given myogenic lineage is not
presently available, but an initial study of MyoD and myo-
genin in the developing mouse embryo has found significant
diversity among different cell populations. By hybridization
to RNA in situ, Sassoon et al. (20) found at least two different
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FIG. 5. RNase protection analyses of herculin, Myf-5, myogenin,
and MyoD transcripts in adult skeletal (thigh) muscle. Total RNA (10
,ug) was hybridized to the following riboprobes: Myf-5 and myogenin
(lane 1), herculin (lane 2), and MyoD (lane 3). The Myf-5 probe was
synthesized from a 382-bp HindI1 fragment that includes the end of
the first exon (see Fig. 1). The other probes were as described in the
legends to Figs. 3 and 4.
Proc. Natl. Acad. Sci. USA 87 (1990)
C-- 0 O
Proc. Nati. Acad. Sci. USA 87 (1990) 1093
patterns of expression coincident with two different types of
muscle, myotomal and limb. They also reported the presence
of determined myoblasts in the limb bud that expressed no
detectable MyoD or myogenin, though some of these myo-
blasts did express detectable levels after 4 or 5 days in
culture. Were these myoblasts initially determined by expres-
sion ofa different myogenic molecule, such as herculin, Myd,
or Myf-5, which later activated expression of MyoD and
myogenin? Such a temporal sequence of expression of these
molecules during development might arise from the circuitry
and changing host-cell influences identified in our cell culture
experiments. This regulatory history could then lead to a final
set of regulators that governs the functional identity of a
mature myocyte.
Note Added in Proof. With respect to expression of Myf-5 (5), Arnold
and coworkers (21) have continued investigation and recently re-
ported that it is absent from smooth muscle. Therefore, herculin and
Myf-5 (as well as MyoD and myogenin) are similar in their restriction
of expression to skeletal muscle.
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